Citation Impact
57 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support
2024 Standout
Works of Maria Learoyd being referenced
In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450
2017
Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors
2013
Author Peers
| Author | Oncology | Molecular Biology | Pharmacology | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Maria Learoyd | 548 | 354 | 157 | 284 | 25 | 980 | |
| Gus Shaver | 25 | 2 | 34 | 1.8k | |||
| Syuichi Takano | 149 | 759 | 26 | 29 | 16 | 1.0k | |
| Yuejü Cui | 2 | 33 | 431 | ||||
| Hyungmin Ahn | 9 | 32 | 2 | 16 | 1.0k | ||
| Shinya Takami | 306 | 348 | 48 | 14 | 20 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...